REG - Seed Innovations Ltd - Continuation of Existing Share Buy-Back Programme

Seed InnovationsAnnouncement

29/02/2024 09:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240229:nRSc9404Ea&default-theme=true

RNS Number : 9404E  Seed Innovations Limited  29 February 2024

This announcement contains inside information for the purposes of Article 7 of
the Market Abuse Regulation (EU) No. 596/2014, as it forms part of UK Domestic
Law by virtue of the European Union (Withdrawal) Act 2018. Upon the
publication of this announcement, this inside information is now considered to
be in the public domain.

 

29 February 2024

SEED Innovations Limited

("SEED" or the "Company")

 

Continuation of Existing Share Buy-Back Programme

 

SEED Innovations Ltd, the AIM-quoted investment company with a portfolio of
disruptive, high-growth life sciences and technology companies, is pleased to
announce that it has extended its existing share repurchase programme (see RNS
dated 19 September 2023) of Ordinary Shares (the "Programme") for up to a
maximum of 21,500,000 shares and £850,000 for a further three months from the
expiry of the original programme term to 30 May 2024. To date, 9,927,000
shares have been bought for c.£288,988.45.

 

Save for the extension of its term, the programme will continue to be run on
the basis set out in the Company's announcement of 19 September 2023.

 

Any purchase of Ordinary Shares made in relation to this announcement will be
carried out on the open market during the period commencing 1 March 2024 and
ending not later than 30 May 2024. The Programme will be funded from the
Company's existing cash resources.

 

Share purchases will take place in open market transactions and may be made
from time to time depending on market conditions, share price, trading volume
and other factors. Shard Capital Partners LLP is the Company's broker in
relation to the Programme. The shares purchased by the Company will be held in
treasury pending cancellation or re-issue.

 

The Programme will be conducted within the safe harbour parameters of the
Market Abuse Regulation 596/2014/EU and the Commission Delegated Regulation
2016/1052/EU (each as incorporated into UK domestic law by the European Union
(Withdrawal) Act 2018, including where relevant pursuant to the Market Abuse
(Amendment) (EU Exit) Regulations 2019). Details of all purchases made
pursuant to the Programme will be announced via RNS and published on the
Company's website as required by the Market Abuse Regulations.

 

-Ends-

 

For further information on the Company please visit:  www.seedinnovations.co
(http://www.seedinnovations.com/) or contact:

 Ed McDermott      SEED Innovations Ltd         E: info@seedinnovations.co

 Lance de Jersey
 James Biddle      Beaumont Cornish Limited,    T: (0)20 7628 3396

 Roland Cornish    Nomad
 Isabella Pierre   Shard Capital Partners LLP   T: (0)20 7186 9927

 Damon Heath       Broker
 Ana Ribeiro       St Brides Partners Ltd,      E: seed@stbridespartners.co.uk

 Isabelle Morris   Financial PR

 

Notes

SEED Innovations Ltd

SEED Innovations Ltd is an AIM-quoted investment company providing
shareholders with exposure to disruptive, high-growth, life sciences and
technology companies. Its strategy is to identify early-stage opportunities
that have an upcoming investment catalyst, and more mature investments that
offer liquidity in the near term. To this end, it currently has eight active
investments with a balance of liquid, pre-liquidity, and longer-term
opportunities and is positioned to move quickly on other investment
opportunities.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  POSEAPANAEXLEEA